-
Mashup Score: 2Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease - 2 month(s) ago
Background In patients with atherosclerotic cardiovascular disease, increasing age is concurrently associated with higher risks of ischemic and bleeding events. The objectives are to determine the …
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease - 2 month(s) ago
Background In patients with atherosclerotic cardiovascular disease, increasing age is concurrently associated with higher risks of ischemic and bleeding events. The objectives are to determine the …
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
Congratulations @ADAPTABLEstudy team! Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic #CVD @JAHA_AHA @schuyler_jones @texhern @G_MarquisGravel https://t.co/DeQBWqy0Aa
-
-
Mashup Score: 1
The deadline to submit an application is Dec. 15, 2023 The ACC and its Diversity and Inclusion Committee invite interested cardiologists, surgeons and PhD trained cardiovascular researchers to apply for the Clinical Trials Research (CTR) program, a year-long opportunity designed to enhance careers and skills in clinical research. In line with goals of the ACC’s Diversity and Inclusion Initiative, this program is intended to increase the number of individuals historically underrepresented in cardiology
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
Calling all #cardiologists, CV #surgeons, PhDs (who completed training by 2023): ✅join @ACCinTouch ✅apply for clinical trials training program NEW: valve/structural You won't regret it! https://t.co/fR32QRScoz @AHAMeetings @pamelasdouglas @TYWangMD @MinnowWalsh
-
-
Mashup Score: 1
The deadline to submit an application is Dec. 15, 2023 The ACC and its Diversity and Inclusion Committee invite interested cardiologists, surgeons and PhD trained cardiovascular researchers to apply for the Clinical Trials Research (CTR) program, a year-long opportunity designed to enhance careers and skills in clinical research. In line with goals of the ACC’s Diversity and Inclusion Initiative, this program is intended to increase the number of individuals historically underrepresented in cardiology
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
Calling all #cardiologists, CV #surgeons, PhDs (who completed training by 2023): ✅join @ACCinTouch ✅apply for clinical trials training program NEW: valve/structural You won't regret it! https://t.co/fR32QRScoz @AHAMeetings @pamelasdouglas @TYWangMD @MinnowWalsh
-
-
Mashup Score: 1Wegovy could reduce heart attack and stroke risk - 6 month(s) ago
Researchers found the medication can reduce your risk of a heart attack or stroke by up to 20 percent. The study published in the New England Journal of Medicine is the first to show this connection.
Source: www.kfyrtv.comCategories: General Medicine News, CardiologistsTweet-
Watch me on TV! Wegovy could reduce #heartattack and #stroke risk https://t.co/yBURz0hzLi @EssentiaHealth
-
-
Mashup Score: 1
The deadline to submit an application is Dec. 15, 2023 The ACC and its Diversity and Inclusion Committee invite interested cardiologists, surgeons and PhD trained cardiovascular researchers to apply for the Clinical Trials Research (CTR) program, a year-long opportunity designed to enhance careers and skills in clinical research. In line with goals of the ACC’s Diversity and Inclusion Initiative, this program is intended to increase the number of individuals historically underrepresented in cardiology
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
Calling all #cardiologists, CV #surgeons, PhDs (who completed training by 2023): ✅join @ACCinTouch ✅apply for clinical trials training program NEW: valve/structural You won't regret it! https://t.co/fR32QRScoz @AHAMeetings @pamelasdouglas @TYWangMD @MinnowWalsh
-
-
Mashup Score: 0Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease - 7 month(s) ago
This post hoc secondary analysis of a randomized clinical trial compares the effectiveness and safety of enteric-coated aspirin vs uncoated aspirin among patients with atherosclerotic cardiovascular disease.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
Congratulations @ADAPTABLEstudy and Dr. Effeon on this paper! Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease https://t.co/WPfXVmmNzL
-
-
Mashup Score: 0I believe in science's Champion Profile | The Gift Goes On 2023 - 8 month(s) ago
Help I believe in science’s champion efforts for The Gift Goes On 2023
Source: www.thegiftgoeson.orgCategories: Cardiologists, Latest HeadlinesTweet-
Help "I believe in science" and support research efforts for Essentia Health Foundation (Duluth/Superior) https://t.co/xT6d68PAr5 @EssentiaHealth
-
-
Mashup Score: 0Scientific Sessions Awards - 12 month(s) ago
Discover the latest award winners in cardiovascular health research. Learn more about Scientific Sessions & stay up-to-date with the American Heart Association.
Source: professional.heart.orgCategories: Cardiologists, Latest HeadlinesTweet-
Be recognized and rewarded at #AHA23 in Philadelphia, Nov. 11-13. Submit your science by June 8, then apply for awards or travel grants! @AHAScience @AHAMeetings To learn more visit https://t.co/jIMB4lzKLB
-
-
Mashup Score: 1WDSE Doctors on Call | Heart Problems & High Blood Pressure | Season 41 | Episode 12 | PBS - 1 year(s) ago
Hosted by Dr. Mary Owen and guests answer viewers’ questions live related to heart…
Source: PBS.orgCategories: Cardiologists, Latest HeadlinesTweet-
Want to learn about #hypertension #afib #cardiacarrest ? Tune in to @PBS: WDSE Doctors on Call, Heart Problems & High Blood Pressure https://t.co/5adjyNMM16 @EssentiaHealth
-
Congratulations @ADAPTABLEstudy team! Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic #CVD @JAHA_AHA @schuyler_jones @texhern @G_MarquisGravel https://t.co/DeQBWqy0Aa